Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. Renowned for its blockbuster drugs like Lipitor ...

Big Data, Bold Visions. The majority of the companies on the CRN 2025 Big Data 100 are either major IT vendors like Amazon ...

Large and mid-cap vaccine makers are, as of now, unworried about their 2025 pipelines in the face of research funding ...

The Indian Council of Medical Research (ICMR) has recommended a ban on Nimesulide for individuals under 18 and over 60 due to ...

Alis Biosciences says its goal is to return to investors billions of dollars stuck on the balance sheets of “moribund” ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Its key asset is the Captisol platform, which over 100 biotech and pharma companies have licensed. Ligand Pharmaceuticals reported fourth-quarter adjusted EPS of $1.27, beating the consensus of $1 ...

“But with these individuals now gone, companies fear we are entering a period of years to build back up an experienced workforce.” One biotech has already received conflicting feedback from a ...

Turbulence in the capital markets is driving biotechnology startups and venture capitalists to consider strategies such as forming closer ties to large pharmaceutical companies. With optimism ...

The firm's analysis indicates a challenging period ahead for the FDA, which may, in turn, affect companies reliant on the drug approval pipeline. For detailed analysis of biotech companies ...

Part of that continuum is understanding where the biotech companies and Big Pharma [are] in order to find ... I think if we come up with good ideas, I’m 100% confident we’ll find people to fund them.” ...